Departamento de Sanidad Animal, Facultad de Veterinaria, Universidad Complutense de Madrid, Madrid, Spain.
Antimicrob Agents Chemother. 2012 May;56(5):2335-41. doi: 10.1128/AAC.06066-11. Epub 2012 Feb 13.
Arm/Rmt methyltransferases have emerged recently in pathogenic bacteria as enzymes that confer high-level resistance to 4,6-disubstituted aminoglycosides through methylation of the G1405 residue in the 16S rRNA (like ArmA and RmtA to -E). In prokaryotes, nucleotide methylations are the most common type of rRNA modification, and they are introduced posttranscriptionally by a variety of site-specific housekeeping enzymes to optimize ribosomal function. Here we show that while the aminoglycoside resistance methyltransferase RmtC methylates G1405, it impedes methylation of the housekeeping methyltransferase RsmF at position C1407, a nucleotide that, like G1405, forms part of the aminoglycoside binding pocket of the 16S rRNA. To understand the origin and consequences of this phenomenon, we constructed a series of in-frame knockout and knock-in mutants of Escherichia coli, corresponding to the genotypes rsmF(+), ΔrsmF, rsmF(+) rmtC(+), and ΔrsmF rmtC(+). When analyzed for the antimicrobial resistance pattern, the ΔrsmF bacteria had a decreased susceptibility to aminoglycosides, including 4,6- and 4,5-deoxystreptamine aminoglycosides, showing that the housekeeping methylation at C1407 is involved in intrinsic aminoglycoside susceptibility in E. coli. Competition experiments between the isogenic E. coli strains showed that, contrary to expectation, acquisition of rmtC does not entail a fitness cost for the bacterium. Finally, matrix-assisted laser desorption ionization (MALDI) mass spectrometry allowed us to determine that RmtC methylates the G1405 residue not only in presence but also in the absence of aminoglycoside antibiotics. Thus, the coupling between housekeeping and acquired methyltransferases subverts the methylation architecture of the 16S rRNA but elicits Arm/Rmt methyltransferases to be selected and retained, posing an important threat to the usefulness of aminoglycosides worldwide.
最近,在致病菌中出现了一种 Arm/Rmt 甲基转移酶,它通过修饰 16S rRNA 上的 G1405 残基(如 ArmA 和 RmtA 到 -E),赋予了对 4,6-二取代氨基糖苷的高水平抗性。在原核生物中,核苷酸甲基化是 rRNA 修饰的最常见类型,它们由各种特定的管家酶进行转录后引入,以优化核糖体的功能。在这里,我们表明,尽管氨基糖苷类抗生素抗性甲基转移酶 RmtC 甲基化 G1405,但它会阻碍管家甲基转移酶 RsmF 在 C1407 位置的甲基化,该核苷酸与 G1405 一样,构成了 16S rRNA 上氨基糖苷结合口袋的一部分。为了了解这一现象的起源和后果,我们构建了一系列大肠杆菌的框内敲除和敲入突变体,对应于 rsmF(+)、ΔrsmF、rsmF(+)rmtC(+)和 ΔrsmF rmtC(+)的基因型。当分析其抗菌药物耐药模式时,ΔrsmF 细菌对氨基糖苷类药物的敏感性降低,包括 4,6-和 4,5-去氧链霉胺氨基糖苷类药物,表明 C1407 处的管家甲基化参与了大肠杆菌固有氨基糖苷类药物的敏感性。同基因大肠杆菌菌株的竞争实验表明,与预期相反,rmtC 的获得并不给细菌带来适应性成本。最后,基质辅助激光解吸电离(MALDI)质谱允许我们确定 RmtC 不仅在存在氨基糖苷类抗生素的情况下,而且在不存在氨基糖苷类抗生素的情况下甲基化 G1405 残基。因此,管家和获得的甲基转移酶之间的偶联破坏了 16S rRNA 的甲基化结构,但却促使 Arm/Rmt 甲基转移酶被选择和保留,这对全球氨基糖苷类药物的有效性构成了重要威胁。